Pierre Beaurang

Insider Reports History

Entity
Individual
Location
C/O Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA
Signature
/s/ Christine Ring, as Attorney-in-Fact for Pierre Beaurang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pierre Beaurang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Chief Business Officer Common Stock 117K $1.17M $10.00 Aug 10, 2021 By Trust
Nurix Therapeutics, Inc. Chief Business Officer Common Stock 4.33K $43.3K $10.00 Aug 10, 2021 Direct
Nurix Therapeutics, Inc. Chief Business Officer Employee Stock Option (right to buy) 6.56K Aug 10, 2021 Direct

Insider Reports Filed by Pierre Beaurang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRIX Nurix Therapeutics, Inc. Aug 10, 2021 4 -$216K 4 Aug 11, 2021 Chief Business Officer
NRIX Nurix Therapeutics, Inc. Jul 12, 2021 4 -$171K 4 Jul 12, 2021 Chief Business Officer
NRIX Nurix Therapeutics, Inc. Jun 10, 2021 5 -$212K 4 Jun 11, 2021 Chief Business Officer
NRIX Nurix Therapeutics, Inc. May 10, 2021 5 -$190K 4 May 11, 2021 Chief Business Officer